Abstract
The life science industry is in a state of constant flux - largely as a result of an unrelenting need for innovation and the threat of competition, both of which can have a dramatic impact on a life science company's profits and future. History has shown that companies, whether pharmaceutical, biotechnology or device focused, must find ways to adapt and be flexible in this challenging environment in order to truly prosper.
Cite
CITATION STYLE
APA
Barratt, R., & Kingston, N. (2007, September). Thinking outside the box. EBR - European Biopharmaceutical Review. https://doi.org/10.69525/jasqde.133
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free